Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 3.4B | 3.9B | 3.7B | 3.6B |
Cost of revenue | 2.1B | 2.3B | 2.2B | 2.2B |
Gross profit | 1.3B | 1.6B | 1.5B | 1.4B |
Operating expense | ||||
Research & development | 544M | 476M | 509M | 488M |
Selling general and admin | 395M | 393M | 390M | 375M |
Other operating expenses | 149M | 245M | 83M | 58M |
Operating income | 318M | 473M | 519M | 496M |
Non operating interest income | ||||
Income | 27M | -8M | 21M | 36M |
Expense | 44M | 49M | 51M | 48M |
Other income expense | — | — | — | — |
Pretax income | 303M | 448M | 492M | 486M |
Tax provision | 60M | 64M | 88M | 92M |
Net income | 246M | -83M | 403M | 394M |
Basic EPS | 0.2 | — | 0.3 | — |
Diluted EPS | 0.2 | — | 0.3 | — |
Basic average shares | 1.3B | — | 1.3B | — |
Diluted average shares | 1.3B | — | 1.3B | — |
EBITDA | 834M | 970M | 1.0B | 1B |
Net income from continuing op. | 243M | 384M | 404M | 394M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 29M | 0 | 0 |